News

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.

Net profit of SMS Pharmaceuticals rose 60.97% to Rs 32.71 crore in the quarter ended March 2026 as against Rs 20.32 crore during the previous quarter ended March 2025. Sales declined 4.13% to Rs 237.95 crore in the quarter ended March 2026 as against Rs 248.20 crore during the previous quarter ended March 2025.For the full year,net profit rose 47.51% to Rs 101.99 crore in the year ended March 2026 as against Rs 69.14 crore during the previous year ended March 2025. Sales rose 13.30% to Rs 886.87 crore in the year ended March 2026 as against Rs 782.75 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales237.95248.20 -4 886.87782.75 13 OPM %16.7716.44 -19.3117.76 - PBDT37.2037.16 0 156.56126.67 24 PBT27.0728.52 -5 116.6492.34 26 NP32.7120.32 61 101.9969.14 48 Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Net profit of SMS Pharmaceuticals rose 28.67% to Rs 23.47 crore in the quarter ended December 2025 as against Rs 18.24 crore during the previous quarter ended December 2024. Sales rose 21.40% to Rs 210.45 crore in the quarter ended December 2025 as against Rs 173.35 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales210.45173.35 21 OPM %20.7419.16 - PBDT41.1831.13 32 PBT31.1622.44 39 NP23.4718.24 29 Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live News